Implant-associated infection

Biofilm Infections

Volumn , Issue , 2011, Pages 69-90

  Zimmerli, Werner ^a   Trampuz, Andrej ^b  

^a Medical University Clinic   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900788062     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-6084-9_5     Document Type: Chapter

References (111)

1. Ahlberg A, Carlsson AS, Lindberg L (1978) Hematogenous infection in total joint replacement. Clin Orthop Relat Res (137):69-75
2. Akhan SE, Dogan Y, Akhan S et al (2008) Pelvic actinomycosis mimicking ovarian malignancy: three cases. Eur J Gynaecol Oncol 29(3):294-297
3. American Academy of Orthopaedic Surgeons. Antibiotic prophylaxis for bacteremia in patients with total joint replacements. Document no 1033. http://www.aaos.org/about/papers/advistmt/1033.asp. Accessed 3 August 2010
4. Antonios VS, Baddour LM (2004) Intra-arterial device infections. Curr Infect Dis Rep 6(4): 263-269
5. Antonios VS, Noel AA, Steckelberg JM et al (2006) Prosthetic vascular graft infection: a risk factor analysis using a case-control study. J Infect 53(1):49-55
6. Baldoni D, Haschke M, Rajacic Z et al (2009) Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection. Antimicrob Agents Chemother 53(3):1142-1148
7. Berardinelli L (2006) Grafts and graft materials as vascular substitutes for haemodialysis access construction. Eur J Vasc Endovasc Surg 32(2):203-211
8. Berbari EF, Osmon DR, Duffy MC et al (2006) Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes. Clin Infect Dis 42(2):216-223
9. Berbari EF, Osmon DR, Carr A et al (2010) Dental procedures as risk factors for prosthetic hip or knee infection: a hospitals based prospective case-control study. Clin Infect Dis 50(1):8-16
10. Brandt CM, Sistrunk WW, Duffy MC et al (1997) Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 24(5):914-919
11. Brause B (2005) Infections with prostheses in bones and joints. In: Mandell GL, Bennet JE, Dolin R (eds) Principles and practice of infectious diseases, 6th edn. WB Saunders, Washington, DC
12. Bressler AM, Zimmer SM, Gilmore JL et al (2004) Peripheral neuropathy associated with prolonged use of linezolid. Lancet Infect Dis 4(8):528-531
13. Bucher E, Trampuz A, Donati L et al (2000) Spondylodiscitis associated with bacteraemia due to coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis 19(2):118-120
14. Byren I, Bejon P, Atkins BL et al (2009) One hundred and twelve infected arthroplasties treated with "DAIR" (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother 63(6):1264-1271
15. Carpenter CF, Chambers HF (2004) Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis 38(7):994-1000
16. Chua JD, Wilkoff BL, Lee I et al (2000) Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 133(8):604-608
17. Chun JK, Schulman MR (2007) The infected breast prosthesis after mastectomy reconstruction: successful salvage of nine implants in eight consecutive patients. Plast Reconstr Surg 120(3):581-589
18. Colyer RA, Capello WN (1994) Surgical treatment of the infected hip implant. Two-stage reimplantation with a one-month interval. Clin Orthop Relat Res (298):75-79
19. Conen A, Walti LN, Merlo A et al (2008) Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period. Clin Infect Dis 47(1):73-82
20. Crockarell JR, Hanssen AD, Osmon DR et al (1998) Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone Joint Surg Am 80(9):1306-1313
21. Darouiche RO (2001) Device-associated infections: a macroproblem that starts with microadher-ence. Clin Infect Dis 33(9):1567-1572
22. Darouiche RO (2004) Treatment of infections associated with surgical implants. N Engl J Med 350(14):1422-1429
23. Davies DG, Parsek MR, Pearson JP et al (1998) The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280(5361):295-298
24. Del Pozo JL, Tran NV, Petty PM et al (2009) Pilot study of association of bacteria on breast implants with capsular contracture. J Clin Microbiol 47(5):1333-1337
25. Drancourt M, Stein A, Argenson JN et al (1997) Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. J Antimicrob Chemother 39(2):235-240
26. Drew RH, Perfect JR, Srinath L et al (2000) Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin- dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study Group. J Antimicrob Chemother 46(5):775-784
27. Elek SD, Conen PE (1957) The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection. Br J Exp Pathol 38(6):573-586
28. Frazier OH, Gemmato C, Myers TJ et al (2007) Initial clinical experience with the HeartMate II axial-flow left ventricular assist device. Tex Heart Inst J 34(3):275-281
29. Frippiat F, Meunier F, Derue G (2004) Place of newer quinolones and rifampicin in the treatment of Gram-positive bone and joint infections. J Antimicrob Chemother 54(6):1158; author reply 1159
30. Gabriel SE, Woods JE, O'Fallon WM et al (1997) Complications leading to surgery after breast implantation. N Engl J Med 336(10):677-682
31. Garzoni C, Kelley WL (2009) Staphylococcus aureus: new evidence for intracellular persistence. Trends Microbiol 17(2):59-65
32. Geissdorfer W, Tandler R, Schlundt C et al (2007) Fatal bioprosthetic aortic valve endocarditis due to Cardiobacterium valvarum. J Clin Microbiol 45(7):2324-2326
33. Giulieri SG, Graber P, Ochsner PE et al (2004) Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 32(4):222-228
34. Gotz F (2002) Staphylococcus and biofilms. Mol Microbiol 43(6):1367-1378
35. Gristina AG, Jennings RA, Naylor PT et al (1989) Comparative in vitro antibiotic resistance of surface-colonizing coagulase-negative staphylococci. Antimicrob Agents Chemother 33(6):813-816
36. Haas D, Kaiser A (2000) Antimicrobial prophyloxis of infections associated with foreign bodies. In: Bisno AL, Waldvogel FA, Infections associated with indwelling medical devices, 3rd ed, Washington, DC
37. Hall-Stoodley L, Costerton JW, Stoodley P (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2(2):95-108
38. Hammermeister K, Sethi GK, Henderson WG et al (2000) Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 36(4):1152-1158
39. Jacobsen SM, Stickler DJ, Mobley HL et al (2008) Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev 21(1):26-59
40. Jassal SV, Lok CE (2008) A randomized controlled trial comparing mupirocin versus Polysporin Triple for the prevention of catheter-related infections in peritoneal dialysis patients (the MP3 study). Perit Dial Int 28(1):67-72
41. John AK, Baldoni D, Haschke M et al (2009) Efficacy of daptomycin in implant-associated infection due to methicillin-resistant staphylococcus aureus (MRSA): the importance of combination with rifampin. Antimicrob Agents Chemother 53:2719-2724
42. Klinge B, Hultin M, Berglundh T (2005) Peri-implantitis. Dent Clin North Am 49(3):661-676, vii-viii
43. Klug D, Balde M, Pavin D et al (2007) Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 116(12): 1349-1355
44. Konig DP, Perdreau-Remington F, Rutt J et al (1998) Slime production of Staphylococcus epider-midis: increased bacterial adherence and accumulation onto pure titanium. Acta Orthop Scand 69(5):523-526
45. Laffer RR, Graber P, Ochsner PE et al (2006) Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect 12(5): 433-439
46. Langlais F (2003) Can we improve the results of revision arthroplasty for infected total hip replacement? J Bone Joint Surg Br 85(5):637-640
47. Lanzetta M, Owen ER (1995) Neo-endothelialisation of PTFE microvascular grafts: a five-year experience. Microsurgery 16(6):404-411
48. Leonhardt A, Dahlen G, Renvert S (2003) Five-year clinical, microbiological, and radiological outcome following treatment of peri-implantitis in man. J Periodontol 74(10):1415-1422
49. Liberatore M, Iurilli AP, Ponzo F et al (1998) Clinical usefulness of technetium-99m-HMPAO-labeled leukocyte scan in prosthetic vascular graft infection. J Nucl Med 39(5): 875-879
50. Lietard C, Thebaud V, Besson G et al (2008) Risk factors for neurosurgical site infections: an 18-month prospective survey. J Neurosurg 109(4):729-734
51. Lucas VS, Lytra V, Hassan T et al (2002) Comparison of lysis filtration and an automated blood culture system (BACTEC) for detection, quantification, and identification of odontogenic bacteremia in children. J Clin Microbiol 40(9):3416-3420
52. Maderazo EG, Judson S, Pasternak H (1988) Late infections of total joint prostheses. A review and recommendations for prevention. Clin Orthop Relat Res (229):131-142
53. Maki DG, Kluger DM, Crnich CJ (2006) The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 81(9):1159-1171
54. Marculescu CE, Berbari EF, Hanssen AD et al (2006) Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 42(4):471-478
55. Marrie TJ, Costerton JW (1984) Morphology of bacterial attachment to cardiac pacemaker leads and power packs. J Clin Microbiol 19(6):911-914
56. Ochsner P, Sirkin M, Trampuz A (2006) Acute infection. In: Ruedi RP, Murphy WM (eds) AO principles of fracture. Management, Stuttgart, Thieme
57. Olsen MA, Chu-Ongsakul S, Brandt KE et al (2008) Hospital-associated costs due to surgical site infection after breast surgery. Arch Surg 143(1):53-60; discussion 61
58. Oxenham H, Bloomfield P, Wheatley DJ et al (2003) Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart 89(7):715-721
59. Pallasch T, Wahl M (2003) Focal infection: new age or ancient history. Endodontic Topics 4:32-45
60. Perez AR, Roxas MF, Hilvano SS (2005) A randomized, double-blind, placebo-controlled trial to determine effectiveness of antibiotic prophylaxis for tension-free mesh herniorrhaphy. J Am Coll Surg 200(3):393-397; discussion 397-398
61. Piraino B, Bailie GR, Bernardini J et al (2005) Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 25(2):107-131
62. Pittet B, Montandon D, Pittet D (2005) Infection in breast implants. Lancet Infect Dis 5(2): 94-106
63. Pittet D, Harbarth S, Ruef C et al (1999) Prevalence and risk factors for nosocomial infections in four university hospitals in Switzerland. Infect Control Hosp Epidemiol 20(1):37-42
64. Qvarfordt PG, Reilly LM, Mark AS et al (1985) Computerized tomographic assessment of graft incorporation after aortic reconstruction. Am J Surg 150(2):227-231
65. Raad I, Hanna H, Maki D (2007) Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 7(10):645-657
66. Ramage G, Tunney MM, Patrick S et al (2003) Formation of Propionibacterium acnes biofilms on orthopaedic biomaterials and their susceptibility to antimicrobials. Biomaterials 24(19): 3221-3227
67. Raut VV, Siney PD, Wroblewski BM (1994) One-stage revision of infected total hip replacements with discharging sinuses. J Bone Joint Surg Br 76(5):721-724
68. Razonable RR, Osmon DR, Steckelberg JM (2004) Linezolid therapy for orthopedic infections. Mayo Clin Proc 79(9):1137-1144
69. Rieger UM, Pierer G, Luscher NJ et al (2009) Sonication of removed breast implants for improved detection of subclinical infection. Aesthetic Plast Surg 33(3):404-408
70. Roumbelaki M, Kritsotakis EI, Tsioutis C et al (2008) Surveillance of surgical site infections at a tertiary care hospital in Greece: incidence, risk factors, microbiology, and impact. Am J Infect Control 36(10):732-738
71. Sanchez-Manuel FJ, Lozano-Garcia J, Seco-Gil JL (2007) Antibiotic prophylaxis for hernia repair. Cochrane Database Syst Rev (3):CD003769
72. Schwank S, Rajacic Z, Zimmerli W et al (1998) Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics. Antimicrob Agents Chemother 42(4):895-898
73. Schwarz F, Bieling K, Sculean A et al (2004) [Treatment of periimplantitis with laser or ultrasound. A review of the literature]. Schweiz Monatsschr Zahnmed 114(12):1228-1235
74. Sculean A, Schwarz F, Becker J (2005) Anti-infective therapy with an Er:YAG laser: influence on peri-implant healing. Expert Rev Med Devices 2(3):267-276
75. Sendi P, Proctor RA (2009) Staphylococcus aureus as an intracellular pathogen: the role of small colony variants. Trends Microbiol 17(2):54-58
76. Sendi P, Rohrbach M, Graber P et al (2006) Staphylococcus aureus small colony variants in prosthetic joint infection. Clin Infect Dis 43(8):961-967
77. Shah Z, Lehman JA Jr, Tan J (1981) Does infection play a role in breast capsular contracture? Plast Reconstr Surg 68(1):34-42
78. Shirtliff ME, Calhoun JH, Mader JT (2001) Comparative evaluation of oral levofloxacin and par-enteral nafcillin in the treatment of experimental methicillin-susceptible Staphylococcus aureus osteomyelitis in rabbits. J Antimicrob Chemother 48(2):253-258
79. Spear SL, Howard MA, Boehmler JH et al (2004) The infected or exposed breast implant: management and treatment strategies. Plast Reconstr Surg 113(6):1634-1644
80. Steckelberg JM, Osmon DR (2000) Prosthetic joint infection. In: Waldvogel FA (ed) 3rd edn ASM Press Washington, DC
81. Suter F, Avai A, Fusco U et al (1994) Teicoplanin versus cefamandole in the prevention of infection in total hip replacement. Eur J Clin Microbiol Infect Dis 13(10):793-796
82. Swain TW, 3rd, Calligaro KD, Dougherty MD (2004) Management of infected aortic prosthetic grafts. Vasc Endovascular Surg 38(1):75-82
83. Tattevin P, Cremieux AC, Pottier P et al (1999) Prosthetic joint infection: when can prosthesis salvage be considered? Clin Infect Dis 29(2):292-295
84. Trampuz A, Hanssen AD, Osmon DR et al (2004) Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med 117(8):556-562
85. Trampuz A, Osmon DR, Hanssen AD et al (2003) Molecular and antibiofilm approaches to prosthetic joint infection. Clin Orthop Relat Res (414):69-88
86. Trampuz A, Piper KE, Jacobson MJ et al (2007) Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 357(7):654-663
87. Trampuz A, Zimmerli W (2005) Prosthetic joint infections: update in diagnosis and treatment. Swiss Med Wkly 135(17-18):243-251
88. Trampuz A, Zimmerli W (2006) Antimicrobial agents in orthopaedic surgery: Prophylaxis and treatment. Drugs 66(8):1089-1105
89. Trampuz A, Zimmerli W (2008) Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis. Curr Infect Dis Rep 10(5):394-403
90. Troidle L, Finkelstein F (2006) Treatment and outcome of CPD-associated peritonitis. Ann Clin Microbiol Antimicrob 5:6
91. Ure KJ, Amstutz HC, Nasser S et al (1998) Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. J Bone Joint Surg Am 80(7):961-968
92. Uslan DZ, Sohail MR, St Sauver JL et al (2007) Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 167(7):669-675
93. Valentine RJ, Timaran CH, Modrall GJ et al (2008) Secondary aortoenteric fistulas versus paraprosthetic erosions: is bleeding associated with a worse outcome? J Am Coll Surg 207(6):922-927
94. van der Ploeg JR (2008) Characterization of Streptococcus gordonii prophage PH15: complete genome sequence and functional analysis of phage-encoded integrase and endolysin. Microbiology 154(Pt 10):2970-2978
95. von Eiff C, Peters G, Becker K (2006) The small colony variant (SCV) concept-the role of staphylococcal SCVs in persistent infections. Injury 37 Suppl 2:S26-33
96. Waddell TK, Rotstein OD (1994) Antimicrobial prophylaxis in surgery. Committee on Antimicrobial Agents, Canadian Infectious Disease Society. CMAJ 151(7):925-931
97. Waldvogel F, Bisno A (2000) Infections associated with indwellling medical devices 3rd edn. ASM Press Washington
98. Wei BP, Robins-Browne RM, Shepherd RK et al (2008) Can we prevent cochlear implant recipients from developing pneumococcal meningitis? Clin Infect Dis 46(1):e1-7
99. Widmer AF, Frei R, Rajacic Z et al (1990) Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 162(1):96-102
100. Widmer AF, Wiestner A, Frei R et al (1991) Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob Agents Chemother 35(4):741-746
101. Williams RJ, Henderson B, Sharp LJ et al (2002) Identification of a fibronectin-binding protein from Staphylococcus epidermidis. Infect Immun 70(12):6805-6810
102. Yamaguchi K, Adams RA, Morrey BF (1998) Infection after total elbow arthroplasty. J Bone Joint Surg Am 80(4):481-491
103. Yao Y, Sturdevant DE, Otto M (2005) Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-soluble modulins in formation of biofilms. J Infect Dis 191(2):289-298
104. Zimmerli W (2008) Antibiotic Therapy. In: Baltensperger M, Eyrich G (eds) Osteomyelitis of the Jaws, 1st edn. Springer, Berlin
105. Zimmerli W, Frei R, Widmer AF et al (1994) Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother 33(5):959-967
106. Zimmerli W, Lew PD, Waldvogel FA (1984) Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest 73(4):1191-1200
107. Zimmerli W, Ochsner PE (2003) Management of infection associated with prosthetic joints. Infection 31(2):99-108
108. Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med 351(16):1645-1654
109. Zimmerli W, Waldvogel FA, Vaudaux P et al (1982) Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis 146(4):487-497
110. Zimmerli W, Widmer AF, Blatter M et al (1998) Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 279(19):1537-1541
111. Zimmerli W, Zak O, Vosbeck K (1985) Experimental hematogenous infection of subcutaneously implanted foreign bodies. Scand J Infect Dis 17(3):303-310